1. Metabolic Enzyme/Protease
  2. Endogenous Metabolite
  3. Palmitoleic acid

Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats.

For research use only. We do not sell to patients.

CAS No. : 373-49-9

Size Price Stock Quantity
Liquid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Liquid
50 mg In-stock
100 mg In-stock
250 mg In-stock
500 mg In-stock
1 g In-stock
5 g In-stock
10 g   Get quote  
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 7 publication(s) in Google Scholar

Other Forms of Palmitoleic acid:

Top Publications Citing Use of Products

    Palmitoleic acid purchased from MedChemExpress. Usage Cited in: FASEB J. 2024 Jul 15;38(13):e23806.  [Abstract]

    Palmitoleic acid (POA; 20 μM; 24 h). The changes in cellular GSH levels were assessed using the GSH content kit.

    Palmitoleic acid purchased from MedChemExpress. Usage Cited in: FASEB J. 2024 Jul 15;38(13):e23806.  [Abstract]

    Palmitoleic acid (POA; 20 μM; 24 h). The alterations in cellular MDA levels were measured using the MDA content kit.

    Palmitoleic acid purchased from MedChemExpress. Usage Cited in: FASEB J. 2024 Jul 15;38(13):e23806.  [Abstract]

    Palmitoleic acid (POA; 20 μM; 24 h). The cellular lipid ROS was detected using C11- BODIPY 581/591 and analyzed by flow cytometry.

    Palmitoleic acid purchased from MedChemExpress. Usage Cited in: FASEB J. 2024 Jul 15;38(13):e23806.  [Abstract]

    Palmitoleic acid (POA; 20 μM; 24 h). Alterations to the mitochondrial membrane potential assessed using fluorescence microscopy.

    Palmitoleic acid purchased from MedChemExpress. Usage Cited in: FASEB J. 2024 Jul 15;38(13):e23806.  [Abstract]

    Palmitoleic acid (POA; 20 μM; 24 h). HUVEC cells were treated with POA, and cell viability was assessed using the CCK8 assay.

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Palmitoleic acid, a composition of fatty acid, is implicated in the prevention of death from cerebrovascular disorders in SHRSP rats.

    IC50 & Target

    Human Endogenous Metabolite

     

    In Vitro

    Palmitoleic acid is a kind of fatty acid in human milk[1]. Among SHRSP given various fatty acids, a diet containing 1% Palmitoleic acid significantly improves the survival rate, with concomitant reduction in the incidence of stroke in spite of their excess NaCl intake through 1% NaCl water for drinking[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    254.41

    Formula

    C16H30O2

    CAS No.
    Appearance

    Liquid (Density: 0.894 g/cm3)

    Color

    Colorless to light yellow

    SMILES

    CCCCCC/C=C\CCCCCCCC(O)=O

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Pure form -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (393.07 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.9307 mL 19.6533 mL 39.3066 mL
    5 mM 0.7861 mL 3.9307 mL 7.8613 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (9.83 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (9.83 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 20 mg/mL (78.61 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.89%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.9307 mL 19.6533 mL 39.3066 mL 98.2666 mL
    5 mM 0.7861 mL 3.9307 mL 7.8613 mL 19.6533 mL
    10 mM 0.3931 mL 1.9653 mL 3.9307 mL 9.8267 mL
    15 mM 0.2620 mL 1.3102 mL 2.6204 mL 6.5511 mL
    20 mM 0.1965 mL 0.9827 mL 1.9653 mL 4.9133 mL
    25 mM 0.1572 mL 0.7861 mL 1.5723 mL 3.9307 mL
    30 mM 0.1310 mL 0.6551 mL 1.3102 mL 3.2756 mL
    40 mM 0.0983 mL 0.4913 mL 0.9827 mL 2.4567 mL
    50 mM 0.0786 mL 0.3931 mL 0.7861 mL 1.9653 mL
    60 mM 0.0655 mL 0.3276 mL 0.6551 mL 1.6378 mL
    80 mM 0.0491 mL 0.2457 mL 0.4913 mL 1.2283 mL
    100 mM 0.0393 mL 0.1965 mL 0.3931 mL 0.9827 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Palmitoleic acid
    Cat. No.:
    HY-W011873
    Quantity:
    MCE Japan Authorized Agent: